Fernando
Aranda Vega
Investigador Colaborador
University of Paris-Saclay
Gif-sur-Yvette, FranciaPublications in collaboration with researchers from University of Paris-Saclay (21)
2020
-
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Nature Communications, Vol. 11, Núm. 1
-
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer (Nature Communications, (2020), 11, 1, (3819), 10.1038/s41467-020-17644-0)
Nature Communications
2018
-
Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
OncoImmunology, Vol. 7, Núm. 6
2017
-
Trial watch: Immune checkpoint blockers for cancer therapy
OncoImmunology, Vol. 6, Núm. 11
2016
-
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Cancer Cell, Vol. 30, Núm. 1, pp. 147-160
2015
-
Immune-dependent antineoplastic effects of cisplatin plus pyridoxine in non-small-cell lung cancer
Oncogene, Vol. 34, Núm. 23, pp. 3053-3062
-
Trial Watch: Adoptive cell transfer for oncological indications
OncoImmunology, Vol. 4, Núm. 11
-
Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
OncoImmunology, Vol. 4, Núm. 4
-
Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications
OncoImmunology, Vol. 4, Núm. 4
-
Trial watch: Naked and vectored DNA-based anticancer vaccines
OncoImmunology, Vol. 4, Núm. 5
2014
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
-
Consensus guidelines for the detection of immunogenic cell death
OncoImmunology, Vol. 3, Núm. 9
-
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy
OncoImmunology, Vol. 3, Núm. 2
-
Trial Watch: Toll-like receptor agonists in oncological indications
OncoImmunology, Vol. 3, Núm. 7
-
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
OncoImmunology, Vol. 3, Núm. 1
-
Trial watch: Adoptive cell transfer for anticancer immunotherapy
OncoImmunology, Vol. 3, Núm. 5
-
Trial watch: Chemotherapy with immunogenic cell death inducers
OncoImmunology, Vol. 3, Núm. 3
-
Trial watch: Dendritic cell-based anticancer therapy
OncoImmunology, Vol. 3, Núm. 11, pp. e963424-1-e963424-16
-
Trial watch: IDO inhibitors in cancer therapy
OncoImmunology, Vol. 3, Núm. 10, pp. e957994-1-e957994-10
-
Trial watch: Immunostimulatory cytokines in cancer therapy
OncoImmunology, Vol. 3, Núm. 6